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A bstract:
Studies have been done on the decay rate o f messenger RNA (mRNA), including 
the decay rate o f EGF-R mRNA. Several factors in the 3’ untranslated region (UTR) have 
been suspected to affect the mRNA decay rate. However, no experiments have been done 
to determine exactly what portion o f the 3’ UTR controls the decay rate. In order to 
study the effects o f segments o f 3’ UTR, it is necessary to start with EGF-R and complete 
3’ UTR. The focus o f this cloning procedure is to produce the EGF-R cDNA with 
complete 3* UTR.
Copy DNA (cDNA) is single stranded DNA that is complementary to an RNA, 
synthesized by the enzyme reverse transcriptase (in vitro). The cDNA contains only the 
exons o f the gene. The EGF-R cDNA refers to the EGF-R cDNA and approximately 150 
base pairs (bp) o f the 3’ untranslated region (UTR). The 3’ UTR is the region that 
extends from the stop codon (termination o f protein synthesis) to the start o f the poly A 
tail.
In this experiment, the EGF-R cDNA and entire 3’ UTR are first isolated. The 
150 bp o f 3* UTR on the EGF-R cDNA is removed. The EGF-R cDNA (without the 150 
bp o f 3* UTR) and the entire 3* UTR are then ligated together, and inserted into a vector 
(i.e. plasmid). This hybrid plasmid will be inserted into a cell line by a process called 
transfection. The stable transfection process results in cells that have incorporated the 
EGF-R cDNA (with complete 3* UTR) into the cell's genome. This allows multiple 
copies of the gene to be made. The cells are lysed, and the DNA can be isolated for study.
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Introduction
This experiment utilizes recombinant DNA technology. In the experiment, a 
vector, and insert are combined. A vector is a circular piece o f DNA found in bacteria. It 
replicates independent o f the bacterial genome. Each time the plasmid replicates, the 
desired gene replicates. The vector used in this cloning procedure contains a gene that 
makes it resistant to the antibiotic ampicillian. This is referred to as the amp gene. This 
gene allows the plasmid to be selected. This is accomplished by adding ampicillian to all 
growth mediums. In this manner, only the bacteria with the amp gene (the desired 
plasmid) will grow.
In this cloning procedure, there are two inserts, the EGF-R cDNA and the 
complete 3 ’ UTR. It is important that both pieces are inserted into the correct order and 
direction. Each piece o f DNA has a 5* and 3’ end. When RNA is produced, the enzyme 
that produces the RNA (RNA polymerase) reads 5* to 3*. By convention, a strand DNA 
is always written 5’ to 3’ (Fig. 1).
Fig. 1 Single Stranded DNA 
5’ end --------------------------  3’ end
Due to the method o f reading by polymerases, it is essential that the EGF-R cDNA 
be upstream (toward the 5’ end) to the 3’ UTR. The 3* UTR must be directly 3’ to the 
EGF-R cDNA. Also, both the EGF-R cDNA and 3* UTR must be put in the correct 
orientation (Fig. 2).
Fig. 2 Correct Insert and Plasmid Orientations
5’^ m 3 ' 5’— ^ ^ — 3’ 5’— ^ — 3’ 5’—^ — ^ — 3’ 
Plasmid EGF-R Gene 3* UTR Plasmid
The cloning strategy entails cutting the DNA at specified points, and putting the 
insert in the correct order. DNA is cut using restriction digests. Bacteria produce 
different enzymes that cut DNA in different places. This is to protect the bacteria against 
foreign DNA from entering its genome. Restriction enzymes recognize specific sequences 
on the DNA and cut at that spot. Commercial plasmids have a multiple cloning site 
(MCS). In this site, unique restriction sites are found. It is important to find a restriction 
site that only cuts the plasmid one time. This will linearize the plasmid. It is also 
important that the restriction site not be located in an important gene o f the plasmid, such 
as the amp gene. This would not allow the bacteria with the plasmid to be selected.
When selecting restriction sites, it is important to choose a sites that produces 
complementary sticky ends. For example, the 3* sticky end o f the linearized plasmid must 
be complementary to the 5* end o f the EGF-R cDNA, and so forth (Fig. 3).
Fig. 3 Correct Plasmid and Inset Overlaps
5’ CATCGTACGACTCGCCATCAGTCGTAGCATTATCGATC 3’ 
GTAGCATGCTGAGCGGGAGTCAGCATCGTAATAGCTAG 
Plasmid EGF-R GENE 3’ UTR Plasmid
Results/Discussion
The EGF-R cDNA is present in the BSEGF-R vector. From this vector, the 
EGF-R cDNA is isolated and cloned into the CMV (pcDNA3) vector. When the EGF-R 
cDNA is cut out o f the BSEGF-R vector, all but a 150 bp fragment o f the 3’ UTR is 
removed. The 150 bp fragment o f the 3’ UTR must be removed. The entire 3’ UTR will 
then be to the EGF-R cDNA. The clonal plasmid will consist o f the CMV vector, the 
EGF-R cDNA, and the entire 3* UTR.
Cloning Strategy 1 The original cloning strategy (Cloning Strategy 1) can be seen 
in flowsheet A1 in appendix A. The original strategy include isolating the three 
components: the EGF-R cDNA, the complete 3* UTR, and an expression vector plasmid. 
Each piece o f DNA was cut with restriction enzymes that produced complementary ends. 
These ends were then to be ligated. Each component had its own unique considerations to 
complete the clone.
EGF-R. The EGF-R cDNA is present in the BSEGF-R vector. The DNA is 
digested with restriction enzymes Sac2 and X hol. This cuts out the EGF-R cDNA (with 
150 bp o f 3* UTR). Sac2 is at the 5’ end, while Xhol is at the 3* end. The length o f the 
EGF-R cDNA is approximately 4 kilobases (kb) long. Within this 150 bp o f 3’ UTR is the 
Acll restriction site. EGF-R cDNA is isolated, and ready for ligation with the CMV 
vector, and 3’ UTR gene.
CMV (pcDNA31 Vector. For ligation, both the CMV vector and EGF-R cDNA 
must have identical restriction sites (two o f them). Both pieces o f DNA had Xhol sites, 
but only EGF-R cDNA has a Sac2 site. It was therefore necessary to produce a Sac2 site 
in the CMV vector. A Bahml site was transformed into a Sac2 site. This was done by 
digesting the pcDNA3 at the Bahml site. This produced cuts with sticky ends. The ends 
were blunt ended, and a Sac2 linker inserted. The vector then had a Sac2 and Xhol sites. 
The CMV DNA was double digested with Sac2 and X ho l.
The EGF-R cDNA (insert) was ligated into the CMV vector. This hybrid 
contained the 150 base pair o f 3’ UTR, and was called CMV-EGF-R
3* UTR. The entire 3* UTR is stored in the pcUTR vector. The 3’ UTR contains 
an Acll site at the 5s end, but no Xhol site. A Sac2 site at the 3’ end o f the UTR was 
then transformed into a Xhol site. This was accomplished by digesting the plasmid with 
Sac2, blunt ending the DNA, and ligating in a Xhol linker. The entire 3’ UTR is then 
digested out with Acll and X hol. This linear insert was then ready to be ligated into the 
CMV-EGF-R.
Prior to ligation o f the 3’ UTR insert into the CMV-EGF-R vector, a problem was 
discovered. The original strategy required that the CMV-EGF-R be digested with Acll 
and Xhol. The entire 3’ UTR, digested with Acll and X hol, was then to be ligated into 
the vector. It was discovered that an Acll site was present in the amp gene o f the CMV- 
EGF-R. Digesting the CMV-EGF-R with Acll (to ligate in the 3* UTR) would destroy
the amp gene. There would be no way to select for the plasmid. This problem resulted in 
cloning strategy 2.
Cloning Strategy 2 The flow sheet for Cloning Strategy 2 can be seen in 
flowsheet A2 in appendix A. The process in this strategy is to clone the entire 3* UTR 
into the CMV-EGF-R plasmid via different restriction sites. The EGF-R is digested with 
Seal and Xhol. The 3’ UTR is digested with the same enzymes, and the CMV-EGF-R 
and entire 3* UTR are cloned together.
BSEGF-R. The EGF-R cDNA was removed from the BSEGF-R plasmid by 
digestion with Sac2 and X ho l. The EGF-R cDNA was cloned into the modified pcDNA3 
to form pcDNA3 (CMV-EGF-R). The EGF-R cDNA contains a Seal site approximately 
1.7 kb upstream from the 3’ Xhol end. The fragment is as follows:
Fig. 4 EGF-R Fragment (4 kb)
/----------- 1.7 k b ----- — /
A— 1.5 k b -■—/
5’ --------------/--------------------------------------------------- /-------- -/- —  3’




This fragment was to be cut at Seal and X hol, and the 3’ UTR cloned in.
pcDNA3. The plan was to abolish the Seal site in the amp gene. This was to be 
accomplished by digesting the pcDNA3 with S eal. This would have produced a blunt end 
cut to which a Clal linker could have been inserted. Once the site was changed, the 
EGF-R cDNA was cloned into it.
3* UTR. The entire 3* UTR was present in the pGemZfS plasmid. The entire 3’ 
UTR was cut out with Seal and Xhol. The plan was to isolated the entire 3’ UTR, and 
clone it into the CMV-EGF-R plasmid.
After further analysis, a potential problem was noted. Replacing the Seal site in 
the amp gene with a Clal linker would lengthen the amp gene. The Seal site was in the 
middle o f the amp gene, the probable coding region. Adding bases at this point may have 
resulted in a mutation that ceased gene function. To overcome this problem, a modified 
version o f this cloning strategy was developed.
Cloning Strategy 3 The flowsheet for this strategy is A3 in appendix A. The idea 
behind this strategy is to partially digest the CMV-EGF-R vector with S eal. The partial 
digestion would result in some o f the DNA being cut in the amp gene, and other DNA to 
be cut in the EGF-R region. The Xhol region would then be cut, and the 3’ UTR cloned 
in. The DNA would be transformed into competent cells, and plated on amp plates.
Those clones with the intact amp gene would survive.
Restriction enzymes, depending on the type and how fresh the enzyme is, have 
different rates o f effectiveness. For the partial digest to work, the rate needed to be 
optimized, so both sites would not be cut. A series o f experiments were run to determine 
the optimal time to perform the partial digest. Five digests were set up. Each digest 
contained a fixed amount o f both the CMV-EGF-R plasmid DNA, and Seal enzyme. The 
digests were incubated in a 37°C water bath for 2 ,4 , 6, 8, and 16 minutes. The reaction
was stopped by adding 1 pi o f 0.5M EDTA. The samples were run on an agarose gel to 
check for double cuts. Photograph #1 in appendix B shows the results o f the digest. All 
the samples resulted in double cuts. Seal turned out to be an extremely efficient enzyme. 
The experiment was repeated with a 1:10 dilution o f the Seal enzyme. Photo #2 in 
appendix B shows that the 2 minute digest resulted in the partial digest. A large (50 pg) 
digest was performed. The digest was run out in a large well, removed, and gene cleaned 
(photo #3). The partially digested CMV-EGF-R was digested with X hol, and gene 
cleaned. This was to produce the CMV-EGF-R vector with a Seal and Xhol sticky end.
The 3’ UTR was to be double digested with Seal and X hol. A problem was 
discovered in that the 3’ UTR was incorrect (no Xhol site). The correct UTR (with the 
Xhol site) was grown up, isolated, and double digested with Seal and Xhol. The DNA 
was gene cleaned and treated with LiCl (for RNA). When the DNA concentration was 
measured using a spectrophotometer, the concentration was very low compared to the 
large pellet after isolation. The suspected problem was the LiCl used. The approximate 
concentration was determined by running a small sample out on a gel. The 3’ UTR 
concentration was less than originally expected, therefore an additional 20 pg o f 3* UTR 
was double digested (Scal/Xhol).
A sample o f insert (2 pi), and plasmid (1 pi) were run out side by side on an 
agarose gel. Both bands had approximately the same intensity. Due to the size difference, 
(at equal intensity) there is approximately 3 times more insert (1.5 kb 3* UTR) than vector 
(9 kb plasmid & EGF-R cDNA). When ligating pieces o f DNA with 2 sticky ends, it is 
optimal to have 4-5 times more inset than vector. Excess insert is desired because o f the 
possibility o f religation o f the plasmid. A large amount o f entire 3* UTR increases the 
chances o f the 3* UTR being inserted into the vector. A  ligation o f the CMV-EGF-R and 
entire 3’ UTR (with 4-5 time greater concentration o f insert) was performed. The DNA 
was transformed into competent cells, and plated on amp plates. No vector/insert colonies 
grew. Growth on the negative control plate was noted. A small sample o f the vector and 
insert were run on a gel to verify that the DNA was correct (photo #4). Each DNA 
looked correct, and the experiment was repeated with the same DNA concentrations. 
Samples o f competent cells, LB growth medium, and TSB/Glucose were plated on amp 
plates as controls. This was to check for contamination at various sources. All three 
control samples grew. This lead to the suspicion that the amp plates did not contain 
ampicillian. New amp plates were made, and a sample o f competent cells were plated.
The competent cells did not grow (ampicillian was present in the plates), and the new amp 
plates were used.
A new ligation was performed, colonies were isolated, grown to 2 ml volume, and 
DNA isolated. The hybrid DNA was digested with X ho l. The DNA did not cut at the 
correct lengths, the bands were all too small.
The hybrid DNA was digested with: (1) X hol, (2) Seal, and (3) Scal/Xhol 
(photo #5). The double digest produced two bands (should be three), and the Seal digest 
produced 1 band (should be two). This suggested that one o f the two Seal sites is either: 
(1) not there, or (2) not cutting.
In an attempt to verify that the hybrid DNA had the entire 3’ UTR insert, the 
hybrid DNA was digested with EcoRl, Xhol, and Seal. The EcoRl enzyme was used
because it is present in the 3’ UTR, and is not present in the plasmid. The results (photo 
#6) suggested that the Seal site may have been missing.
At this point, the orientation o f the 3* UTR was also in question. If  the 3* UTR 
was in anti-sense (3* to 5’) to the CMV-EGF-R, then the digested DNA bands would be 
different sizes than expected. To check the direction o f the 3* UTR, a digest with Aval 
(5* end) and Sacl (3* end) was performed. This digest should have produced a 1.5 kb 
band. The results suggested that the 3’ UTR was in antisense to the CMV-EGF-R
To verify the orientation, the DNA was sequenced. The 3* UTR was found to be 
in the correct orientation. The results that were obtained were inconsistent with the 
sequencing. How/why this occurred was unknown. At this point, this cloning strategy 
was discontinued, and a new cloning strategy developed.
Cloning Strategy 4 The flowsheet for this strategy is A4 in appendix A. This 
strategy was to produce the correct entire 3’ UTR by polymerase chain reaction (PCR). 
This ensured that the insert was correct. The PCR insert was ligated into a pGem5 T 
plasmid (appendix C). The vector contained a lac Z gene. This gene was cut, and has 
overhanging thymine bases. These thymine bases are put on for ligation to the adenine 
bases put on the PCR product. I f  an insert were ligated into the gene the colony would be 
white. If  no insert was put in, the plasmid would self-ligate, and the intact lac Z gene 
would produce a blue colony. This blue-white selection made selecting for the colonies 
with inserts easier. The ligation was very inefficient. Several ligations were attempted, 
and none o f the colonies contained the insert. This process was continued, and a second 
strategy started.
The second strategy was to cut the pGem3Zf plasmid with B am H l. This would 
produce a blunt end cut. A sample o f 3’ UTR was blunt ended. The two pieces o f DNA 
were to be ligated together. This strategy was put on hold when a colony o f pGem5 
plasmid was found to possibly contain the 3’ UTR. This is the point where the clone is 
currently at.
Conclusions
This cloning procedure turned out to be much more difficult, and time consuming 
than originally expected. The procedure could have been more efficient with less 
laboratory mistakes. These mistakes resulted in procedures being repeated. Some 
problems could not have been avoided. For example, optimal concentrations o f DNA 
needed to be determined for ligations. A Promega manual’s instructions did not produce 
good results. The partial digest o f Seal also took time to find the optimal digestion 
period. These were time consuming laboratory steps that could not be controlled.
Other factors, such as the disappearing Seal site, could not be controlled. These 
factors resulted in wasted time because other factors were considered in error. When an 
enzyme did not cut, the enzyme was used to digest a different plasmid to ensure the 
enzyme was working. Various steps such as this slowed the process down.
The clone is not finished at this time, but appears close to completion. It would 
greatly benefit future cloners to have each piece o f DNA sequenced before ligation. It 
would also benefit future experimenters to know all the restriction sites in selective genes 
(i.e. amp gene) before attempting ligations. These steps will save the experimenter time 
and frustration.
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Appendix C - Restriction M aps
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